Vaginal administration of low-dose conjugated estrogens: Systemic absorption and effects on the endometrium

Obstetrics and Gynecology

Volumn 84, Issue 2, 1994, Pages 215-218

  Handa, Victoria L ^a   Bachus, Kevin E ^a   Johnston, William W ^a   Robboy, Stanley J ^a   Hammond, Charles B ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ABSORPTION; DRUG EFFECT; ENDOMETRIUM; FEMALE; HUMAN; INTRAVAGINAL DRUG ADMINISTRATION; POSTMENOPAUSE; PRIORITY JOURNAL; VAGINA ATROPHY;

ADMINISTRATION, INTRAVAGINAL; AGED; ATROPHY; BIOPSY; BLOOD FLOW VELOCITY; CELL DIVISION; ENDOMETRIUM; ESTRADIOL; ESTROGENS, CONJUGATED (USP); ESTRONE; FEMALE; HUMANS; MIDDLE AGED; POSTMENOPAUSE; RHEOLOGY; TIME FACTORS; VAGINITIS;

EID: 0028129192     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Iosif SC, Bekassy Z. Prevalence of genito-urinary symptoms in the late menopause. Acta Obstet Gynecol Scand 1984;63:257-60.
2. Luisi M, Franchi F, Kicovic PM. A group-comparative study of effects of Ovestin cream versus Premarin cream in postmenopausal women with vaginal atrophy. Maturitas 1980;2: 311-9.
3. Martin PL, Yen SSC, Burnier AAM, Hermann H. Systemic absorption and sustained effects of vaginal estrogen creams. JAMA 1979;242:2699-700.
4. Mandel FP, Geola FL, Meldrum DR, et al. Biological effects of various doses of vaginally administered conjugated equine estrogens in postmenopausal women. J Clin Endocrinol Metab 1983; 57:133-9.
5. Kennedy DL, Baum C, Forbes MB. Noncontraceptive estrogens and progestins: Use patterns over time. Obstet Gynecol 1985;65: 441-6.
6. Widholm O, Vartiainen E. The absorption of conjugated oestrogen and sodium oestrone sulfate from the vagina. Ann Chir Gynaecol Fenn 1974;63:186-90.
7. American College of Obstetricians and Gynecologists. Hormone replacement therapy. ACOG technical bulletin no. 93. Washington, DC: American College of Obstetricians and Gynecologists, 1992.
8. Nasri MN, Shepherd JH, Setchell ME, Lowe DG, Chard T. The role of vaginal scan in measurement of endometrial thickness in postmenopausal women. Br J Obstet Gynaecol 1991;98:470-5.
9. Goldstein SR, Nachtigall M, Snyder JR, Nachtigall L. Endometrial assessment by vaginal ultrasonography before endometrial sampling with postmenopausal bleeding. Am J Obstet Gynecol 1990;163:119-23.
10. Hilliard TC, Bourne TH, Whitehead MI, Crayford TB, Collins WP, Campbell S. Differential effects of transdermal estradiol and sequential progestogens on impedance to flow within the uterine arteries of postmenopausal women. Fertil Steril 1992;58:959-63.
11. Bourne TH, Campbell S, Steer CV, Royston P, Whitehead MI, Collins WP. Detection of endometrial cancer by transvaginal ultrasonography with color flow imaging and blood flow analysis: A preliminary report. Gynecol Oncol 1991;40:253-9.
12. DeZiegler T, Hillard TC, Whitehead MI, Frydman R. Vascular resistance of uterine arteries: Physiological effects of estradiol and progesterone. Fertil Steril 1991;55:775-9.
13. Bourne T, Hilliard TC, Whitehead MI, Crook D, Campbell S. Oestrogens, arterial status, and postmenopausal women. Lancet 1990;335:1470-1.
14. Novak ER, Woodruff JD. Novak's gynecologic and obstetric pathology. 8th ed. Philadelphia: WB Saunders, 1979:694-708.
15. DeVane GW, Czekala NM, Judd HJ, Yen SSC. Circulating gonadotropins, estrogens, and androgens in polycystic ovarian disease. Am J Obstet Gynecol 1975;121:496-501.
16. Speroff L, Glass RH, Kase NG. Clinical gynecologic endocrinology and infertility. 4th ed. Baltimore: Williams & Wilkins, 1989: 129.
17. Rigg LA, Hermann H, Yen SSC. Absorption of estrogens from vaginal creams. N Engl J Med 1978;298:195-7.